
Pacliwel 100mg Injection
Marketer
Getwell Pharma (I) Pvt Ltd
Salt Composition
Paclitaxel (100mg)
Overview Pacliwel 100mg Injection
Oncaspar, a 100mg injectable anticancer agent, treats breast, pancreatic, and non-small-cell lung cancers. Administered intravenously by a healthcare professional, dosage and frequency are determined by your physician based on your condition and may vary. Strictly adhere to your doctor's prescribed regimen; incorrect usage or overdose can lead to severe adverse reactions. Therapeutic effects may take weeks or months to manifest; discontinue only under medical supervision. Common side effects include nausea, vomiting, and fatigue. Serious side effects such as edema (hand and lip swelling), alopecia (hair loss), and weight increase are possible. Concomitant medication may mitigate these; report unexplained bruising/bleeding, sore throat, mouth sores, or fever immediately. This medication can lower blood cell counts (red and white), increasing infection risk. Regular blood tests monitoring blood cell levels and liver function are vital. Prior to treatment, disclose any cardiac, hepatic, or renal issues, or current use of anti-infectives. Interactions with other medications are possible; inform your physician of all medications you are taking. This medication is contraindicated during pregnancy and breastfeeding; effective contraception for both partners is crucial throughout treatment.
Uses of Pacliwel 100mg Injection
Cancers affecting the breast, lungs (non-small cell type), and pancreas.
Major Benefits of Pacliwel 100mg Injection:
This medication will be administered by your healthcare provider; please do not attempt self-medication.
Common Side effects of Pacliwel 100mg Injection:
- Nausea
- Vomiting
- Weakness
- Low blood platelets
- Rash
- Upper respiratory tract infection
- Urinary tract infection
- Bleeding
- Anemia (low number of red blood cells)
- Flushing (sense of warmth in the face, ears, neck and trunk)
- Hair loss
- Decreased blood pressure
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Diarrhea
- Decreased white blood cell count (neutrophils)
How to use Pacliwel 100mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Pacliwel 100mg Injection works:
Oncaspar 100mg Injection is a chemotherapeutic agent. Its mechanism of action involves disrupting microtubule networks, essential for cancer cell proliferation. This inhibits cancerous growth, ultimately leading to cell death.
SAFETY ADVICE
AlcoholUNSAFE
Combining alcohol and Pacliwel 100mg Injection is not recommended due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Administering Pacliwel 100mg Injection to pregnant individuals is contraindicated due to established harm to the fetus. In exceptional circumstances involving life-threatening conditions, a physician might consider its use if the potential advantages outweigh the risks. Always seek medical advice.
Breast feedingUNSAFE
Administering Pacliwel 100mg Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Pacliwel 100mg Injection can induce adverse reactions that might impair driving ability. While driving between treatment cycles isn't inherently prohibited, the medication's alcohol content suggests caution regarding operating a vehicle.
KidneySAFE IF PRESCRIBED
Pacliwel 100mg Injection poses no known safety risk for individuals with kidney conditions; dose modification isn't typically required. Nevertheless, consultation with a physician is advisable for patients with pre-existing kidney disease.
LiverCAUTION
Pacliwel 100mg Injection requires careful administration for individuals with hepatic impairment. Dosage modification of Pacliwel 100mg Injection might be necessary. Physician consultation is advised. Pacliwel 100mg Injection is contraindicated in patients exhibiting severe liver dysfunction.
What if you forget to take Pacliwel 100mg Injection :
NA
Facts to Know About Pacliwel 100mg Injection
| Label | Value |
|---|---|
| Chemical Classification | Taxane-Based Compounds |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Behavioral Class | Taxanes: Antimicrotubule Agents |
